Pharmatech Oncology's Presentation at 46th Annual DIA Meeting

Denver, Colorado - June 25, 2010

(Denver, Colorado) – June 25, 2010 – Eric Lynam, VP of Business Development for Pharmatech Oncology, led a session at the 46th Annual Drug Information Association Meeting earlier this month. The session was well-attended and generated a great discussion.

Please click here to see Mr. Lynam’s presentation.

About Pharmatech Oncology, Inc.

Pharmatech Oncology, headquartered in Denver, Colorado, is a Research Management Organization (RMO) dedicated to the highest quality of clinical research. Pharmatech Oncology provides oncology-specific Site Management Organization (SMO) and Contract Research Organization (CRO) services to its network of primarily community-based clinics. While experienced in oncology studies, the company’s separate Data Management business entity is also capable of providing services for research projects in other disease indications. Pharmatech Oncology’s dedication to rapid enrollment and quality data ensures successful development and utilization of therapeutic products among sponsors, investigators, and patients.

For more information about Pharmatech Oncology, please visit www.pharmatechoncology.com.

For more information about Compass IRB, please visit www.compassirb.com